The role of ECT in depression

Author/s
Ellen Hartland, Vimal Sivasanker
Citation
Issue 5 Winter 2018
CEPiP.2018.1.130-135
Abstract

Electro-convulsive therapy (ECT) remains an important, potentially life-saving tool in the treatment of depression. Its efficacy in depression is second to none, yet it remains underused by psychiatrists. It is a very safe treatment, safer than antidepressants in some patients. Adverse effects, particularly memory impairment, are increasingly better managed with improved treatment parameters, such as the use of high-dose unilateral ECT. National guidelines support the use of ECT, although not as robustly as the Royal College of Psychiatrists, which recommends earlier consideration and use of ECT than is currently the case. ECT was the first neuromodulation treatment for depression. Several others have since been developed, supported by a variable degree and quality of evidence.

Cite as: Cutting Edge Psychiatry in Practice 2018, 5(1):130-135; https://doi.org/10.65031/jqnw5002

References

  1. Carney S, Cowen P, Dearness K, Eastaugh J. Efficacy and safety of electroconvulsive therapy in depressive disorders: A systematic review and meta-analysis. The Lancet. 2003 Mar 8;361(9360):799. https://doi.org/10.1016/s0140-6736(03)12705-5
  2. Greenhalgh J, Knight C, Hind D, Beverley C, Walters S. Clinical and cost-effectiveness of electroconvulsive therapy for depressive illness, schizophrenia, catatonia and mania: systematic reviews and economic modelling studies. Health Technology Assessment (Winchester, England). 2005 Mar;9(9):1. https://doi.org/10.3310/hta9090
  3. Husain MM, Rush AJ, Fink M, Knapp R, Petrides G, Rummans T, Biggs MM, O'Connor K, Rasmussen K, Litle M, Zhao W. Speed of response and remission in major depressive disorder with acute electroconvulsive therapy (ECT): a Consortium for Research in ECT (CORE) report. The Journal of Clinical Psychiatry. 2004 Apr. https://doi.org/10.4088/jcp.v65n0406
  4. Eranti S, Mogg A, Pluck G, Landau S, Purvis R, Brown RG, Howard R, Knapp M, Philpot M, Rabe-Hesketh S, Romeo R. A randomized, controlled trial with 6-month follow-up of repetitive transcranial magnetic stimulation and electroconvulsive therapy for severe depression. American Journal of Psychiatry. 2007 Jan;164(1):73-81. https://doi.org/10.1176/ajp.2007.164.1.73
  5. McFarquhar TF, Thompson J. Knowledge and attitudes regarding electroconvulsive therapy among medical students and the general public. The Journal of ECT. 2008 Dec 1;24(4):244-53. https://doi.org/10.1097/yct.0b013e318168be4a
  6. Payne NA, Prudic J. Electroconvulsive therapy part II: A biopsychosocial perspective. Journal of Psychiatric Practice. 2009 Sep;15(5):369. https://doi.org/10.1097/01.pra.0000361278.73092.85
  7. Murray CJ, Vos T, Lozano R, Naghavi M, Flaxman AD, Michaud C, Ezzati M, Shibuya K, Salomon JA, Abdalla S, Aboyans V. Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010. The Lancet. 2012 Dec 15;380(9859):2197-223. https://doi.org/10.1016/s0140-6736(12)62134-5
  8. The Stationery Office. Psychiatric morbidity among adults living in private households, 2000. London, UK: The Stationery Office; 2001.
  9. Waite J, Easton A (editors). The ECT handbook. 3rd ed. London, UK: RCPsych Publications; 2013.       
  10. Kho KH, van Vreeswijk MF, Simpson S, Zwinderman AH. A meta-analysis of electroconvulsive therapy efficacy in depression. The Journal of ECT. 2003 Sep 1;19(3):139-47. https://doi.org/10.1097/00124509-200309000-00005
  11. Pagnin D, de Queiroz V, Pini S, Cassano GB. Efficacy of ECT in depression: a meta-analytic review. The Journal of ECT. 2004 Mar 1;20(1):13-20. https://doi.org/10.1097/00124509-200403000-00004
  12. Janakiramaiah N, Gangadhar BN, Murthy PN, Harish MG, Subbakrishna DK, Vedamurthachar A. Antidepressant efficacy of Sudarshan Kriya Yoga (SKY) in melancholia: a randomized comparison with electroconvulsive therapy (ECT) and imipramine. Journal of Affective Disorders. 2000 Jan 1;57(1-3):255-9. https://doi.org/10.1016/s0165-0327(99)00079-8
  13. Folkerts HW, Michael N, Tölle R, Schonauer K, Mücke S, Schulze‐Mönking H. Electroconvulsive therapy vs. paroxetine in treatment‐resistant depression - a randomized study. Acta Psychiatrica Scandinavica. 1997 Nov;96(5):334-42. https://doi.org/10.1111/j.1600-0447.1997.tb09926.x
  14. Thase ME. The small specific effects of antidepressants in clinical trials: what do they mean to psychiatrists? Current Psychiatry Reports. 2011 Dec 1;13(6):476-82. https://doi.org/10.1007/s11920-011-0235-x
  15. Gibbons RD, Hur K, Brown CH, Davis JM, Mann JJ. Benefits from antidepressants: synthesis of 6-week patient-level outcomes from double-blind placebo-controlled randomized trials of fluoxetine and venlafaxine. Archives of General Psychiatry. 2012 Jun 1;69(6):572-9. https://doi.org/10.1001/archgenpsychiatry.2011.2044
  16. Trivedi MH, Rush AJ, Wisniewski SR, Nierenberg AA, Warden D, Ritz L, Norquist G, Howland RH, Lebowitz B, McGrath PJ, Shores-Wilson K. Evaluation of outcomes with citalopram for depression using measurement-based care in STAR* D: Implications for clinical practice. American Journal of Psychiatry. 2006 Jan 1;163(1):28-40. https://doi.org/10.1176/appi.ajp.163.1.28
  17. Van Dierman L, Van Den Ameele S, Kamperman AM, Sabbe BC, Vermeulen T, Schrijvers D, Birkenhäger TK. Prediction of electroconvulsive therapy response and remission in major depression: meta-analysis. The British Journal of Psychiatry. 2018 Feb;212(2):71-80 https://doi.org/10.1192/bjp.2017.28
  18. Elias A, Phutane VH, Clarke S, Prudic J. Electroconvulsive therapy in the continuation and maintenance treatment of depression: systematic review and meta-analyses. Australian & New Zealand Journal of Psychiatry. 2018 May; 52(5):415-24 https://doi.org/10.1177/0004867417743343
  19. Flint AJ, Gagnon N. Effective use of electroconvulsive therapy in late-life depression. The Canadian Journal of Psychiatry. 2002 Oct;47(8):734-41. https://doi.org/10.1177/070674370204700804
  20. Watts BV, Groft A, Bagian JP, Mills PD. An examination of mortality and other adverse events related to electroconvulsive therapy using a national adverse event report system. The Journal of ECT. 2011 Jun 1;27(2):105-8. https://doi.org/10.1097/yct.0b013e3181f6d17f
  21. Kerner N, Prudic J. Current electroconvulsive therapy practice and research in the geriatric population. Neuropsychiatry. 2014 Feb;4(1):33. https://doi.org/10.2217/npy.14.3
  22. Philibert RA, Richards L, Lynch CF, Winokur G. Effect of ECT on mortality and clinical outcome in geriatric unipolar depression. The Journal of Clinical Psychiatry. 1995 Sep;56(9):390.               
  23. Gálvez V, Ho KA, Alonzo A, Martin D, George D, Loo CK. Neuromodulation therapies for geriatric depression. Current Psychiatry Reports. 2015 Jul 1;17(7):59. https://doi.org/10.1007/s11920-015-0592-y
  24. Spodniakova B, Halmo M, Nosáľová P. Electroconvulsive therapy in pregnancy-A review. Journal of Obstetrics and Gynaecology. 2015 Oct 3;35(7):659-62. https://doi.org/10.3109/01443615.2014.990427
  25. Pompili M, Dominici G, Giordano G, Longo L, Serafini G, Lester D, Amore M, Girardi P. Electroconvulsive treatment during pregnancy: a systematic review. Expert Review of Neurotherapeutics. 2014 Dec 1;14(12):1377-90. https://doi.org/10.1586/14737175.2014.972373
  26. Yonkers KA, Wisner KL, Stowe Z, Leibenluft E, Cohen L, Miller L, Manber R, Viguera A, Suppes T, Altshuler L. Management of bipolar disorder during pregnancy and the postpartum period. American Journal of Psychiatry. 2004 Apr 1;161(4):608-20. https://doi.org/10.1176/appi.ajp.161.4.608
  27. Miller LJ. Use of electroconvulsive therapy during pregnancy. Hospital & Community Psychiatry. 1994;45(5):444- 50.          
  28. Burrell-Ward H, Fromson JA, Cooper JJ, De Oliveira G, Almeida M. Recommendations for the use of ECT in pregnancy: literature review and proposed clinical protocol. Archives of Women's Mental Health. 2018 May 23:1-8 https://doi.org/10.1007/s00737-018-0851-0
  29. Vasavada MM, Leaver AM, Njau S, Joshi SH, Ercoli L, Hellermann G, Narr KL, Espinosa R. Short-and-long-term cognitive outcomes in patients with major depression treated with electroconvulsive therapy. The Journal of ECT. 2017 Dec 1;33(4):278-85 https://doi.org/10.1097/yct.0000000000000426
  30. Philpot M, Collins C, Trivedi P, Treloar A, Gallacher S, Rose D. Eliciting users' views of ECT in two mental health trusts with a user-designed questionnaire. Journal of Mental Health. 2004 Aug 1;13(4):403-13. https://doi.org/10.1080/09638230410001729843
  31. Loo CK, Schweitzer I, Pratt C. Recent advances in optimizing electroconvulsive therapy. Australian & New Zealand Journal of Psychiatry. 2006 Aug;40(8):632-8. https://doi.org/10.1080/j.1440-1614.2006.01862.x
  32. Robertson H, Pryor R. Memory and cognitive effects of ECT: informing and assessing patients. Advances in Psychiatric Treatment. 2006;12:228-38. https://doi.org/10.1192/apt.12.3.228
  33. Semkovska M, Landau S, Dunne R, Kolshus E, Kavanagh A, Jelovac A, Noone M, Carton M, Lambe S, McHugh C, McLoughlin DM. Bitemporal versus high-dose unilateral twice-weekly electroconvulsive therapy for depression (EFFECT-Dep): a pragmatic, randomized, non-inferiority trial. American Journal of Psychiatry. 2016 Feb 19;173(4):408-17. https://doi.org/10.1176/appi.ajp.2015.15030372
  34. Gartlehner G, Hansen RA, Morgan LC, Thaler K, Lux L, Van Noord M, Mager U, Thieda P, Gaynes BN, Wilkins T, Strobelberger M. Comparative benefits and harms of second-generation antidepressants for treating major depressive disorder: an updated meta-analysis. Annals of Internal Medicine. 2011 Dec 6;155(11):772-85. https://doi.org/10.7326/0003-4819-155-11-201112060-00009
  35. Joint Formulary Committee. British National Formulary (online) London: BMJ Group and Pharmaceutical Press http://www.medicinescomplete.com [accessed 4/3/16].
  36. Ganguli A, Mascarenhas RC, Jamshed N, Tefera E, Veis JH. Hyponatremia: incidence, risk factors, and consequences in the elderly in a home-based primary care program. Clinical Nephrology. 2015 Aug;84(2):75-85. https://doi.org/10.5414/cn108453
  37. National Institute for Health and Care Excellence (NICE). Depression in adults: recognition and management: Clinical guideline [CG90]. National Institute for Health and Care Excellence (NICE); 2018. https://doi.org/10.1007/978-1-349-94186-5_836
  38. Fink M. Is the practice of ECT ethical? The World Journal of Biological Psychiatry. 2005 Jan 1;6(sup2):38-43. https://doi.org/10.1080/15622970510030054
  39. Geduldig ET, Kellner CH. Electroconvulsive therapy in the elderly: new findings in geriatric depression. Current Psychiatry Reports. 2016 Apr 1;18(4):40. https://doi.org/10.1007/s11920-016-0674-5
  40. National Institute for Health and Care Excellence (NICE). Repetitive transcranial magnetic stimulation for depression: Interventional procedures guidance [IPG542]. NICE; 2015.     
  41. Müller HH, Moeller S, Lücke C, Lam AP, Braun N, Philipsen A. Vagus nerve stimulation (VNS) and other augmentation strategies for therapy-resistant depression (TRD): review of the evidence and clinical advice for use. Frontiers in Neuroscience. 2018 Apr 10;12:239 https://doi.org/10.3389/fnins.2018.00239 s
  42. Palm U, Hasan A, Strube W, Padberg F. tDCS for the treatment of depression: a comprehensive review. European Archives of Psychiatry and Clinical Neuroscience. 2016 Dec 1;266(8):681-94. https://doi.org/10.1007/s00406-016-0674-9
  43. Daskalakis ZJ, Sun Y. Novel stimulation approaches with ECT: why everything old may be new again. Neuropsychopharmacology. 2017 Jul;42(8):1561 https://doi.org/10.1038/npp.2017.42